Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06116799 · ClinicalTrials.gov registry record · NA
Managing Pain in Patients With Plantar Fasciitis - A Blinded Randomized Controlled Trial
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT06116799: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT06116799 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06116799, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Plantar fasciitis (PF), a leading cause of persistent heel pain, results in almost a million physician visits annually. Conservative treatment is often the first line of management with insoles being frequently prescribed. While multiple studies have compared insoles based on the degree of customization to foot contour, the literature is lacking in data comparing insoles based on their material. In this randomized clinical trial, we compared the early effects of polyethylene (PE), polyurethane (PU), and carbon fiber insoles in the treatment of PF, using a set of patient-reported outcomes.
Interventions
- DEVICE Orthotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2023-05-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06116799
The ClinicalTrials.gov registry entry for NCT06116799 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Orthotic is the first listed.
NCT06116799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06116799 about?
NCT06116799 is a clinical study titled "Managing Pain in Patients With Plantar Fasciitis - A Blinded Randomized Controlled Trial". Plantar fasciitis (PF), a leading cause of persistent heel pain, results in almost a million physician visits annually. Conservative treatment is often the first line of management with insoles being frequently prescribed. While multiple studies have compared insoles based on the degree of customiza...
What is the current status of trial NCT06116799?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2022-04-01. Estimated completion is 2023-05-06.
What interventions are being tested in trial NCT06116799?
The interventions under investigation include: Orthotic (DEVICE).
Who is sponsoring clinical trial NCT06116799?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.